Cross Country Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Cross Country HealthcareDie Umsatzerlöse des Unternehmens werden voraussichtlich um 6.2% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 70.2% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 68.8% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 4.9% betragen.

Wichtige Informationen

71.5%

Wachstumsrate der Gewinne

71.0%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	19.3%
Wachstumsrate der Einnahmen	-6.9%
Zukünftige Eigenkapitalrendite	4.3%
Analystenabdeckung	Good
Zuletzt aktualisiert	20 Sep 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Jul 31

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Feb 22

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Feb 09

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Oct 09

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

Sep 13

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Aug 19

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Jun 26

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Jun 08

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Apr 28

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Mar 15

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Mar 02

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Jan 20

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Jan 05

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Oct 29

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Oct 14

Paring My Cross Country Healthcare Gains

Sep 29

Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Sep 26

Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC

Sep 14

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:CCRN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,343	29	N/A	N/A	3
12/31/2025	1,319	23	74	82	8
12/31/2024	1,349	-6	114	123	8
6/30/2024	1,575	8	159	171	N/A
3/31/2024	1,776	46	195	208	N/A
12/31/2023	2,020	73	235	248	N/A
9/30/2023	2,234	102	228	241	N/A
6/30/2023	2,428	124	298	311	N/A
3/31/2023	2,641	156	200	210	N/A
12/31/2022	2,807	188	125	134	N/A
9/30/2022	2,819	227	47	56	N/A
6/30/2022	2,558	216	-95	-87	N/A
3/31/2022	2,136	175	-98	-90	N/A
12/31/2021	1,677	132	-93	-86	N/A
9/30/2021	1,252	59	-16	-10	N/A
6/30/2021	1,071	34	-21	-16	N/A
3/31/2021	956	9	-20	-15	N/A
12/31/2020	836	-13	23	27	N/A
9/30/2020	836	-19	15	20	N/A
6/30/2020	851	-21	10	14	N/A
3/31/2020	837	-58	7	10	N/A
12/31/2019	822	-58	3	6	N/A
9/30/2019	808	-76	7	10	N/A
6/30/2019	800	-74	24	28	N/A
3/31/2019	801	-20	16	21	N/A
12/31/2018	816	-17	16	21	N/A
9/30/2018	835	31	34	39	N/A
6/30/2018	863	38	34	38	N/A
3/31/2018	868	41	N/A	57	N/A
12/31/2017	865	38	N/A	46	N/A
9/30/2017	868	2	N/A	27	N/A
6/30/2017	854	9	N/A	43	N/A
3/31/2017	845	-13	N/A	29	N/A
12/31/2016	834	8	N/A	30	N/A
9/30/2016	804	10	N/A	32	N/A
6/30/2016	785	1	N/A	25	N/A
3/31/2016	778	21	N/A	21	N/A
12/31/2015	767	4	N/A	18	N/A
9/30/2015	762	-10	N/A	18	N/A
6/30/2015	756	-22	N/A	7	N/A
3/31/2015	686	-28	N/A	5	N/A
12/31/2014	618	-32	N/A	-4	N/A
9/30/2014	539	-64	N/A	-6	N/A
6/30/2014	458	-55	N/A	-1	N/A
3/31/2014	446	-54	N/A	1	N/A
12/31/2013	438	-54	N/A	9	N/A
9/30/2013	441	-4	N/A	16	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CCRNDas prognostizierte Gewinnwachstum (70.2% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: CCRNDie Erträge des Unternehmens (70.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.9% pro Jahr).

Hohe Wachstumserträge: CCRNEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: CCRNDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-9% pro Jahr).

Hohe Wachstumseinnahmen: CCRNDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-9% pro Jahr).

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CCRNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (4.7%).

Cross Country Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates have been downgraded.

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Consensus EPS estimates fall by 40%

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Consensus EPS estimates fall by 36%

Price target decreased by 14% to US$25.25

Recent updates

Consensus EPS estimates have been downgraded.

Insider recently sold US$236k worth of stock

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Investor sentiment improves as stock rises 19%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold US$137k worth of stock

Consensus EPS estimates fall by 40%

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold US$105k worth of stock

Consensus EPS estimates fall by 36%

Full year 2023 earnings: EPS misses analyst expectations

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Now 20% undervalued after recent price drop

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Chief Administrative Officer notifies of intention to sell stock

Senior VP & Chief Accounting Officer recently sold US$147k worth of stock

Investor sentiment deteriorates as stock falls 19%

Insider recently sold US$131k worth of stock

Third quarter 2023 earnings: EPS misses analyst expectations

Price target decreased by 14% to US$25.25

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Price target decreased by 7.3% to US$27.80

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

New minor risk - Profit margin trend

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

Consensus EPS estimates fall by 13%

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Price target decreased by 9.1% to US$35.75

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 16%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Price target increased to US$39.33

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Executive VP notifies of intention to sell stock

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Investor sentiment improved over the past week

Paring My Cross Country Healthcare Gains